Lü Caixia, a member of the Standing Committee of the National People’s Congress, conducted a research visit to Zhongke Keli Company!

Symposium at the Hongshan Hotel in Wuhan

On December 11, 2020, Wan Gang, Vice Chairman of the National Committee of the Chinese People’s Political Consultative Conference, President of the China Association for Science and Technology, Chairman of the Central Committee of the China Zhi Gong Party, and former Minister of Science and Technology; Lü Caixia, Member of the Standing Committee of the National People’s Congress, Deputy Chairperson of the Environmental Protection and Resources Conservation Committee, and Vice Chairperson of the Central Committee of the China Zhi Gong Party; Xu Xudong, Vice Chairman of the Wuhan Municipal Committee of the Chinese People’s Political Consultative Conference, Vice Chairperson of the Hubei Provincial Committee of the China Zhi Gong Party, and Chairman of the Wuhan Municipal Committee; and Zhou Tianlei, Secretary-General of the Hubei Provincial Committee of the China Zhi Gong Party and Vice Chairperson of the Wuhan Municipal Committee, along with nearly one hundred entrepreneur representatives from across the country, held a cordial meeting at the Hongshan Hotel in Wuhan. Yan Zibao, President of Wuhan Zhongke Keli Optoelectronic Technology Co., Ltd., was invited to attend the symposium as an observer.

At the symposium, leaders at all levels, led by Wan Gang, Vice Chairman of the National Committee of the Chinese People’s Political Consultative Conference, and Lü Caixia, a member of the Standing Committee of the National People’s Congress, conveyed the nation’s earnest expectations for major enterprises to drive economic revitalization in the post‑pandemic era. Participants engaged in in-depth discussions on topics such as how Chinese companies can forge new avenues for development amid pandemic control measures, strategies for building a new development pattern of dual circulation, and related considerations on the growth of the private sector.

Site visit for research by Zhongke Keli Company

On the morning of December 12, 2020, Lü Caixia, a member of the Standing Committee of the National People’s Congress, led more than 70 representatives—including national, provincial, and municipal leaders as well as business executives—to Wuhan Zhongke Keli Optoelectronic Technology Co., Ltd. for a fact-finding visit.

President Yan Zibao of Zhongke Keli, Assistant to the President Pan Dina, and other staff members provided全程接待 and extended their heartfelt gratitude to all attendees who came for this fact-finding visit. President Yan Zibao led the delegation on an on-site tour of key areas, including the office space, exhibition hall, various production workshops, and the product R&D center. He offered a detailed overview of the company’s development journey, its product‑development capabilities, and its current core offerings. In particular, he addressed the company’s situation over the past nearly six months since resuming work and production following the pandemic, such as the rights‑protection efforts related to “Shumin Zhixing” and the smart injector, among others. Early, Mid-, and Late-Stage Cancer Screening System The progress of R&D on key projects, as well as the implementation of epidemic prevention measures and production operations across all aspects of the company’s work.

Upon arrival, all attendees first visited the Zhongke Keli exhibition hall, where they gained an in-depth understanding of the company’s development journey and its core product portfolio. Cutting-edge, specialized product lines—including the Shumin Star, the Disruption Star, the Shumin Light, the Radical Sculpting Star, the smart injector, and the early-to-mid‑stage cancer screening system—impressed the leaders and experts, who also commended Zhongke Keli’s advanced philosophy of driving growth through innovation.

Factory Tour

R&D Technology Center

President Yan Zibao stated that he will closely follow the country’s development trajectory, With the expectations of its leaders, Zhongke Keli has intensified its development efforts, increasing R&D investment in core products such as the “intelligent syringe” and the “early-, mid-, and late-stage cancer screening system,” while enhancing its capacity for independent innovation and placing a strong emphasis on the creation and protection of proprietary knowledge and intellectual property. Uphold the entrepreneurial spirit, continuously strive to improve in patriotism, innovation, integrity, social responsibility, and global vision, stay committed to one’s core business, work tirelessly, lead enterprises through current challenges, and endeavor to become… A model for private enterprises, Helping China’s economy take off.